DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19âA Therapeutic Approach of Choice in Type 2 Diabetic Patients?
Smelcerovic, Andrija, Kocic, Gordana, Gajic, Mihajlo, Tomovic, Katarina, Djordjevic, Vukica, Stankovic-Djordjevic, Dobrila, Anderluh, MarkoVolume:
11
Journal:
Frontiers in Pharmacology
DOI:
10.3389/fphar.2020.01185
Date:
August, 2020
File:
PDF, 375 KB
2020